Human medicines European Public Assessment Report (EPAR): Ixiaro, Japanese encephalitis vaccine (inactivated, adsorbed), Revision: 3, Authorised
Related Biotechnology, Pharmaceutical and Healthcare News
Human medicines European Public Assessment Report (EPAR): Ixiaro, Japanese-encephalitis vaccine (inactivated, adsorbed), Revision: 4, Authorised
Human medicines European Public Assessment Report (EPAR): Ixiaro, Japanese encephalitis vaccine (inactivated, adsorbed), Revision: 4, Authorised
Human medicines European Public Assessment Report (EPAR): Cervarix, human papillomavirus vaccine [types 16, 18] (recombinant, adjuvanted, adsorbed), Revision: 12, Authorised
Human medicines European Public Assessment Report (EPAR): Prepandrix, prepandemic influenza vaccine (H5N1) (split virion, inactivated, adjuvanted), Revision: 7, Authorised
Human medicines European Public Assessment Report (EPAR): Pumarix, pandemic influenza vaccine (H5N1) (split virion, inactivated, adjuvanted), Revision: 2, Authorised
Original Article: Human medicines European Public Assessment Report (EPAR): Ixiaro, Japanese encephalitis vaccine (inactivated, adsorbed), Revision: 3, Authorised
NEXT ARTICLE
More From BioPortfolio on "Human medicines European Public Assessment Report (EPAR): Ixiaro, Japanese encephalitis vaccine (inactivated, adsorbed), Revision: 3, Authorised"
Search BioPortfolio:
